SAPS-113 - The policy process and legislative reform enabling pharmacy-led substitution of biological medicines in Finland

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: SAPS-113
• By: KYLLöNEN, Henna (Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland)
• Co-author(s): Mrs Henna Kyllönen (Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland / The Association of Finnish Pharmacies, Helsinki, Finland)
  Dr (PhD Pharm) Marja Airaksinen (Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland)
  Dr (PhD Pharm) Hanna M. Tolonen (HUS Pharmacy, HUS Helsinki University Hospital, Helsinki, Finland)
  
• Abstract:

  Introduction
  Biosimilars have been part of European pharmaceutical legislation since 2003. In the same year, Finland introduced generic substitution for small-molecule medicines, resulting in significant direct cost savings for patients and public budgets, especially when combined with the reference pricing system, implemented in Finland 2009...

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login